2026 NPPES data Medical Oncology Physician NPI 1457526535 MD , MPH
Verify on CMS →

Sreekanth Donepudi, MD , MPH

Medical Oncology Physician in Kansas City, Missouri.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,815 in Medical Oncology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
684
Medicare Part D claims · 163 beneficiaries · Medical Oncology Physician avg: 689
Generic prescribing
82%
generic claims · 18% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$41.08
2 payments · CMS Open Payments (Sunshine Act)
Compiled from official public sources by the PlainDoctor editorial team.

What the federal data shows

Sreekanth Donepudi, MD , MPH filed 684 Medicare Part D claims in 2023 as a Medical Oncology Physician in Kansas City, Missouri, prescribing 82% generic.

684
Part D claims, 2023
82%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Sreekanth Donepudi, MD , MPH's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023, across all CMS prescribers nationally

684 Top 31% higher than 69% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). Below this entry. 600–800: 56,224 prescribers (4%). This entry sits in this band. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2K+: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board certification likely (heuristic, not verified)

Sreekanth Donepudi, MD , MPH practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Sreekanth Donepudi, MD , MPH?

Quality data not reported

NPI registry status

Active

Issued 04/29/2008

NPI 1457526535

Primary specialty

Medical Oncology Physician

Niche

3,815 US NPIs in this specialty

Medicare Part D claims

684 1% vs specialty avg

2023 prescription claims

Specialty avg: 689

Specialty distribution in Missouri

How Medical Oncology Physician compares to other specialties among Missouri providers

Missouri providers
Pharmacist - 4.8%Pharmacist4.8%Professional Counselor - 4.8%Professional Counselor4.8%Speech-Language Pathologist - 4.5%Speech-Language Pathologist4.5%Clinical Social Worker - 4.5%Clinical Social Worker4.5%Family Nurse Practitioner - 4.3%Family Nurse Practitioner4.3%Physical Therapist - 4%Physical Therapist4%Medical Oncology Physician - 0.1%Medical Oncology Physician0.1%
Largest specialties in Missouri (% of in-state providers)

Board certification

Not published by CMS

CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Medical Oncology Physician. Verify directly:

How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Sreekanth Donepudi, MD , MPH appears in the CMS NPPES registry as a Medical Oncology Physician provider holding MD , MPH credentials at 5844 NW BARRY RD STE 40, Kansas City, MO, 64154, with a listed phone of (816) 880-3876. NPI 1457526535 was issued on 04/29/2008.

Medicare Part D records for calendar year 2023 show 684 prescription claims written by this provider, covering 163 Medicare beneficiaries and totaling roughly $1.0 million in drug spend, split 18% brand-name and 82% generic by claim count, with an opioid prescribing rate of 7.6%.

Medical Oncology Physician is a narrow specialty nationwide, with 3,815 enrolled providers across 53 states and an average of 689 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.

Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5844 NW BARRY RD STE 40
Kansas City, MO 64154

Provider Details

NPI 1457526535
Specialty Medical Oncology Physician
Credentials MD , MPH
Gender Male
NPI Issued 04/29/2008

Hospital and facility affiliations

Facilities where Sreekanth Donepudi, MD , MPH bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Saint Lukes Physician Group Inc
Liberty, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) - CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sreekanth Donepudi, MD , MPH. Source: openpaymentsdata.cms.gov.

Total received

$41

Largest payer

AstraZeneca Pharmaceuticals LP

Most common payment type

Education

Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Brand vs generic prescribing mix · Typical

Sreekanth Donepudi, MD , MPH - brand share 18.0%
Medical Oncology Physician average

18% brand-name claims vs 82% generic, on 684 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

684
Total Claims
$1.0M
Total Drug Cost
163
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
958
Total Day Supply
25,116
Brand vs Generic
18% brand / 82% generic
Brand Drug Cost
$988K
Generic Drug Cost
$33K
Opioid Claims
52 (7.6% rate)
Antibiotic Claims
18

Patient Demographics

Average Patient Age
73.5 years
Avg HCC Risk Score
2.15
Gender Split
67% female / 33% male
Age Distribution
<65: 15, 65-74: 71, 75-84: 63, 85+: 14

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What Sreekanth Donepudi, MD , MPH prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Letrozole
70
Ondansetron Hcl
62
Gabapentin
45
Prednisone
36
Tamoxifen Citrate
33
Eliquis
Apixaban
31
Loperamide
Loperamide Hcl
26
Tramadol Hcl
19
Acyclovir
16
Anastrozole
16

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Medical Oncology Physician Overview

How Sreekanth Donepudi, MD , MPH fits within the Medical Oncology Physician landscape nationally.

3,815
Medical Oncology Physician Providers in US
53
States with Medical Oncology Physician
689
Avg Claims per Provider

Sreekanth Donepudi, MD , MPH's 684 claims are below the specialty average of 689.

Nearby Medical Oncology Physician Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as Donepudi.

Compare Medical Oncology Physician nationally: see state-by-state distribution →

Before you book an appointment

Use this federal record as your verification checklist, not as a recommendation.

  • Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
  • Check the active license and any disciplinary history with the Missouri medical board, federal registration is not a license check. Credential verification guide
  • Weigh a second option: compare this provider with a nearby Medical Oncology Physician peer on Medicare volume and prescribing patterns. Compare providers

Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.

Frequently Asked Questions

What is Sreekanth Donepudi, MD , MPH's specialty?
Sreekanth Donepudi, MD , MPH specializes in Medical Oncology Physician and practices in Kansas City, Missouri. Credentials: MD , MPH.
How much does Sreekanth Donepudi, MD , MPH prescribe under Medicare Part D?
In 2023, Sreekanth Donepudi, MD , MPH wrote 684 Medicare Part D claims totaling $1.0M in drug costs for 163 beneficiaries.
Where is Sreekanth Donepudi, MD , MPH located?
Sreekanth Donepudi, MD , MPH is located at 5844 NW BARRY RD STE 40, Kansas City, MO, 64154. Phone: (816) 880-3876.
What is Sreekanth Donepudi, MD , MPH's NPI number?
Sreekanth Donepudi, MD , MPH's National Provider Identifier (NPI) is 1457526535, issued on 04/29/2008.
Does Sreekanth Donepudi, MD , MPH prescribe more brand-name or generic drugs?
Sreekanth Donepudi, MD , MPH's prescribing is 18% brand-name and 82% generic drugs by claim count, with $988K in brand drug costs.
Does Sreekanth Donepudi, MD , MPH prescribe opioids?
Yes, Sreekanth Donepudi, MD , MPH had 52 opioid claims in 2023 with an opioid prescribing rate of 7.6%.
How many Medical Oncology Physician providers are there in the US?
There are 3,815 Medical Oncology Physician providers across 53 states in the US. The average Medical Oncology Physician provider writes 689 Medicare Part D claims per year.
What drugs does Sreekanth Donepudi, MD , MPH prescribe most often?
Based on 2023 Medicare Part D data, Sreekanth Donepudi, MD , MPH's most frequently prescribed drugs include Letrozole, Ondansetron Hcl, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Sreekanth Donepudi, MD , MPH accept Medicare?
Sreekanth Donepudi, MD , MPH appears in CMS Medicare data with 684 Part D claims and 163 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Sreekanth Donepudi, MD , MPH's credentials?
Sreekanth Donepudi, MD , MPH's NPI is 1457526535 with credentials MD , MPH. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Compiled from official public sources by the PlainDoctor editorial team.

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.